Skip to main content

Advertisement

SpringerLink
Log in

MHC class I immune evasion in MCMV infection

  • Review
  • Published:
Medical Microbiology and Immunology Aims and scope Submit manuscript

Abstract

Murine cytomegalovirus (MCMV) is a well-studied model of natural β-herpesvirus infection. However, many questions remain regarding its control by and evasion of the immune response it generates. CD8 and CD4 T cells have both unique and redundant roles in control of the virus that differ based on the immunocompetence of the infected mice. MCMV encodes major histocompatibility complex (MHC) class I immune evasion genes that can have an impact in vitro, but their role in infection of immunocompetent mice has been difficult to identify. This review addresses the evidence for their in vivo function and suggests why they may be evolutionarily conserved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Smith MG (1954) Propagation of salivary gland virus of the mouse in tissue cultures. Proc Soc Exp Biol Med 86:435–440

    Article  CAS  PubMed  Google Scholar 

  2. Singleton GR, Smith AL, Shellam GR, Fitzgerald N, Muller WJ (1993) Prevalence of viral antibodies and helminths in field populations of house mice (Mus domesticus) in southeastern Australia. Epidemiol Infect 110:399–417

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Singleton GR, Smith AL, Krebs CJ (2000) The prevalence of viral antibodies during a large population fluctuation of house mice in Australia. Epidemiol Infect 125:719–727

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Moro D, Lloyd ML, Smith AL, Shellam GR, Lawson MA (1999) Murine viruses in an island population of introduced house mice and endemic short-tailed mice in Western Australia. J Wildl Dis 35:301–310

    Article  CAS  PubMed  Google Scholar 

  5. Gorman S, Harvey NL, Moro D, Lloyd ML, Voigt V, Smith LM, Lawson MA, Shellam GR (2006) Mixed infection with multiple strains of murine cytomegalovirus occurs following simultaneous or sequential infection of immunocompetent mice. J Gen Virol 87:1123–1132

    Article  CAS  PubMed  Google Scholar 

  6. Booth TW, Scalzo AA, Carrello C, Lyons PA, Farrell HE, Singleton GR, Shellam GR (1993) Molecular and biological characterization of new strains of murine cytomegalovirus isolated from wild mice. Arch Virol 132:209–220

    Article  CAS  PubMed  Google Scholar 

  7. Farroway LN, Gorman S, Lawson MA, Harvey NL, Jones DA, Shellam GR, Singleton GR (2005) Transmission of two Australian strains of murine cytomegalovirus (MCMV) in enclosure populations of house mice (Mus domesticus). Epidemiol Infect 133:701–710

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Pollock JL, Virgin HWt (1995) Latency, without persistence, of murine cytomegalovirus in the spleen and kidney. J Virol 69:1762–1768

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kurz S, Steffens HP, Mayer A, Harris JR, Reddehase MJ (1997) Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 71:2980–2987

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Koffron AJ, Hummel M, Patterson BK, Yan S, Kaufman DB, Fryer JP, Stuart FP, Abecassis MI (1998) Cellular localization of latent murine cytomegalovirus. J Virol 72:95–103

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Mercer JA, Spector DH (1986) Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice. J Virol 57:497–504

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Henson D, Strano AJ (1972) Mouse cytomegalovirus. Necrosis of infected and morphologically normal submaxillary gland acinar cells during termination of chronic infection. Am J Pathol 68:183–202

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Reddehase MJ, Balthesen M, Rapp M, Jonjic S, Pavic I, Koszinowski UH (1994) The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 179:185–193

    Article  CAS  PubMed  Google Scholar 

  14. Reddehase MJ, Weiland F, Munch K, Jonjic S, Luske A, Koszinowski UH (1985) Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol 55:264–273

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Koffron AJ, Mueller KH, Kaufman DB, Stuart FP, Patterson B, Abecassis MI (1995) Direct evidence using in situ polymerase chain reaction that the endothelial cell and T-lymphocyte harbor latent murine cytomegalovirus. Scand J Infect Dis Suppl 99:61–62

    CAS  PubMed  Google Scholar 

  16. Pollock JL, Presti RM, Paetzold S, Virgin HWt (1997) Latent murine cytomegalovirus infection in macrophages. Virology 227:168–179

    Article  CAS  PubMed  Google Scholar 

  17. Jonjic S, Pavic I, Polic B, Crnkovic I, Lucin P, Koszinowski UH (1994) Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med 179:1713–1717

    Article  CAS  PubMed  Google Scholar 

  18. Gold MC, Munks MW, Wagner M, McMahon CW, Kelly A, Kavanagh DG, Slifka MK, Koszinowski UH, Raulet DH, Hill AB (2004) Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response. J Immunol 172:6944–6953

    Article  CAS  PubMed  Google Scholar 

  19. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296:1323–1326

    Article  CAS  PubMed  Google Scholar 

  20. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV, Iizuka K, Furukawa H, Beckman DL, Pingel JT et al (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 99:8826–8831

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Shellam GR, Flexman JP (1986) Genetically determined resistance to murine cytomegalovirus and herpes simplex virus in newborn mice. J Virol 58:152–156

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Quinnan GVJ, Manischewitz JF (1987) Genetically determined resistance to lethal murine cytomegalovirus infection is mediated by interferon-dependent and -independent restriction of virus replication. J Virol 61:1875–1881

    Article  PubMed  PubMed Central  Google Scholar 

  23. Allan JE, Shellam GR (1984) Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice. Arch Virol 81:139–150

    Article  CAS  PubMed  Google Scholar 

  24. Scalzo AA, Fitzgerald NA, Wallace CR, Gibbons AE, Smart YC, Burton RC, Shellam GR (1992) The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol 149:581–589

    Article  CAS  PubMed  Google Scholar 

  25. Katzenstein DA, Yu GS, Jordan MC (1983) Lethal infection with murine cytomegalovirus after early viral replication in the spleen. J Infect Dis 148:406–411

    Article  CAS  PubMed  Google Scholar 

  26. Krmpotic A, Busch DH, Bubic I, Gebhardt F, Hengel H, Hasan M, Scalzo AA, Koszinowski UH, Jonjic S (2002) MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol 3:529–535

    Article  CAS  PubMed  Google Scholar 

  27. Iizuka K, Nakajima C, Iizuka YM, Takase M, Kato T, Noda S, Tanaka K, Kanagawa O (2007) Protection from lethal infection by adoptive transfer of CD8 T cells genetically engineered to express virus-specific innate immune receptor. J Immunol 179:1122–1128

    Article  CAS  PubMed  Google Scholar 

  28. Scalzo AA, Lyons PA, Fitzgerald NA, Forbes CA, Shellam GR (1995) The BALB.B6-Cmv1r mouse: a strain congenic for Cmv1 and the NK gene complex. Immunogenetics 41:148–151

    Article  CAS  PubMed  Google Scholar 

  29. Lathbury LJ, Allan JE, Shellam GR, Scalzo AA (1996) Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection. J Gen Virol 77:2605–2613

    Article  CAS  PubMed  Google Scholar 

  30. Bukowski JF, Woda BA, Welsh RM (1984) Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol 52:119–128

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Shanley JD (1990) In vivo administration of monoclonal antibody to the NK 1.1 antigen of natural killer cells: effect on acute murine cytomegalovirus infection. J Med Virol 30:58–60

    Article  CAS  PubMed  Google Scholar 

  32. Welsh RM, Brubaker JO, Vargas-Cortes M, O’Donnell CL (1991) Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J Exp Med 173:1053–1063

    Article  CAS  PubMed  Google Scholar 

  33. Lawson CM, Grundy JE, Shellam GR (1988) Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. J Gen Virol 69:1987–1998

    Article  PubMed  Google Scholar 

  34. Tolpin MD, Starr SE, Arbeter AM, Plotkin SA (1980) Inactivated mouse cytomegalovirus vaccine: preparation, immunogenicity, and protective effect. J Infect Dis 142:569–574

    Article  CAS  PubMed  Google Scholar 

  35. Farrell HE, Shellam GR (1991) Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies. J Gen Virol 72:149–156

    Article  CAS  PubMed  Google Scholar 

  36. Rapp M, Messerle M, Buhler B, Tannheimer M, Keil GM, Koszinowski UH (1992) Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus. J Virol 66:4399–4406

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Xu J, Lyons PA, Carter MD, Booth TW, Davis-Poynter NJ, Shellam GR, Scalzo AA (1996) Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus. J Gen Virol 77:49–59

    Article  CAS  PubMed  Google Scholar 

  38. Geoffroy F, Moachon N, Rodwell J, Quash GA (1996) Murine cytomegalovirus inactivated by sodium periodate is innocuous and immunogenic in mice and protects them against death and infection. Vaccine 14:1686–1694

    Article  CAS  PubMed  Google Scholar 

  39. Polic B, Hengel H, Krmpotic A, Trgovcich J, Pavic I, Luccaronin P, Jonjic S, Koszinowski UH (1998) Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188:1047–1054

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Jonjic S, Mutter W, Weiland F, Reddehase MJ, Koszinowski UH (1989) Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J Exp Med 169:1199–1212

    Article  CAS  PubMed  Google Scholar 

  41. Jonjic S, Pavic I, Lucin P, Rukavina D, Koszinowski UH (1990) Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. J Virol 64:5457–5464

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Koszinowski UH (1991) Molecular aspects of immune recognition of cytomegalovirus. Transplant Proc 23:70–73, discussion 74

    CAS  PubMed  Google Scholar 

  43. Reddehase MJ, Jonjic S, Weiland F, Mutter W, Koszinowski UH (1988) Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors. J Virol 62:1061–1065

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Alterio de Goss M, Holtappels R, Steffens HP, Podlech J, Angele P, Dreher L, Thomas D, Reddehase MJ (1998) Control of cytomegalovirus in bone marrow transplantation chimeras lacking the prevailing antigen-presenting molecule in recipient tissues rests primarily on recipient-derived CD8 T cells. J Virol 72:7733–7744

    Article  Google Scholar 

  45. Reddehase MJ, Mutter W, Munch K, Buhring HJ, Koszinowski UH (1987) CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 61:3102–3108

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Koszinowski UH, Reddehase MJ, Keil GM, Volkmer H, Jonjic S, Messerle M, del Val M, Mutter W, Munch K, Buhler B (1987) Molecular analysis of herpesviral gene products recognized by protective cytolytic T lymphocytes. Immunol Lett 16:185–192

    Article  CAS  PubMed  Google Scholar 

  47. Holtappels R, Podlech J, Pahl-Seibert MF, Julch M, Thomas D, Simon CO, Wagner M, Reddehase MJ (2004) Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J Exp Med 199:131–136

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Fitzgerald NA, Papadimitriou JM, Shellam GR (1990) Cytomegalovirus-induced pneumonitis and myocarditis in newborn mice. A model for perinatal human cytomegalovirus infection. Arch Virol 115:75–88

    Article  CAS  PubMed  Google Scholar 

  49. Fitzgerald NA, Shellam GR (1991) Host genetic influences on fetal susceptibility to murine cytomegalovirus after maternal or fetal infection. J Infect Dis 163:276–281

    Article  CAS  PubMed  Google Scholar 

  50. Grundy JE, Mackenzie JS, Stanley NF (1981) Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect Immun 32:277–286

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Shellam GR, Flexman JP, Farrell HE, Papadimitriou JM (1985) The genetic background modulates the effect of the beige gene on susceptibility to cytomegalovirus infection in mice. Scand J Immunol 22:147–155

    Article  CAS  PubMed  Google Scholar 

  52. Bukowski JF, Warner JF, Dennert G, Welsh RM (1985) Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J Exp Med 161:40–52

    Article  CAS  PubMed  Google Scholar 

  53. Krmpotic A, Messerle M, Crnkovic-Mertens I, Polic B, Jonjic S, Koszinowski UH (1999) The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo. J Exp Med 190:1285–1296

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Reusch U, Muranyi W, Lucin P, Burgert HG, Hengel H, Koszinowski UH (1999) A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J 18:1081–1091

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Ziegler H, Thale R, Lucin P, Muranyi W, Flohr T, Hengel H, Farrell H, Rawlinson W, Koszinowski UH (1997) A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6:57–66

    Article  CAS  PubMed  Google Scholar 

  56. Wagner M, Gutermann A, Podlech J, Reddehase MJ, Koszinowski UH (2002) Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med 196:805–816

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Holtappels R, Gillert-Marien D, Thomas D, Podlech J, Deegen P, Herter S, Oehrlein-Karpi SA, Strand D, Wagner M, Reddehase MJ (2006) Cytomegalovirus encodes a positive regulator of antigen presentation. J Virol 80:7613–7624

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Pinto AK, Munks MW, Koszinowski UH, Hill AB (2006) Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis. J Immunol 177:3225–3234

    Article  CAS  PubMed  Google Scholar 

  59. Gold MC, Munks MW, Wagner M, Koszinowski UH, Hill AB, Fling SP (2002) The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo. J Immunol 169:359–365

    Article  CAS  PubMed  Google Scholar 

  60. Munks MW, Gold MC, Zajac AL, Doom CM, Morello CS, Spector DH, Hill AB (2006) Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus. J Immunol 176:3760–3766

    Article  CAS  PubMed  Google Scholar 

  61. Reddehase MJ, Koszinowski UH (1984) Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection. Nature 312:369–371

    Article  CAS  PubMed  Google Scholar 

  62. Reddehase MJ, Fibi MR, Keil GM, Koszinowski UH (1986) Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes. J Virol 60:1125–1129

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Holtappels R, Grzimek NK, Simon CO, Thomas D, Dreis D, Reddehase MJ (2002) Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions. J Virol 76:6044–6053

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Pinto AK, Jamieson AM, Raulet DH, Hill AB (2007) The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40. J Virol 81:12564–12571

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. LoPiccolo DM, Gold MC, Kavanagh DG, Wagner M, Koszinowski UH, Hill AB (2003) Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus. J Virol 77:301–308

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Hengel H, Reusch U, Geginat G, Holtappels R, Ruppert T, Hellebrand E, Koszinowski UH (2000) Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus. J Virol 74:7861–7868

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Kavanagh DG, Gold MC, Wagner M, Koszinowski UH, Hill AB (2001) The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J Exp Med 194:967–978

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. del Val M, Hengel H, Hacker H, Hartlaub U, Ruppert T, Lucin P, Koszinowski UH (1992) Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J Exp Med 176:729–738

    Article  PubMed  Google Scholar 

  69. Smith LM, Shellam GR, Redwood AJ (2006) Genes of murine cytomegalovirus exist as a number of distinct genotypes. Virology 352:450–465

    Article  CAS  PubMed  Google Scholar 

  70. Munks MW, Cho KS, Pinto AK, Sierro S, Klenerman P, Hill AB (2006) Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J Immunol 177:450–458

    Article  CAS  PubMed  Google Scholar 

  71. Holtappels R, Pahl-Seibert MF, Thomas D, Reddehase MJ (2000) Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs. J Virol 74:11495–11503

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Karrer U, Sierro S, Wagner M, Oxenius A, Hengel H, Koszinowski U, Phillips RE, Klenerman P (2003) Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol 171:3895

    Article  CAS  Google Scholar 

  73. Karrer U, Sierro S, Wagner M, Oxenius A, Hengel H, Koszinowski UH, Phillips RE, Klenerman P (2003) Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol 170:2022–2029

    Article  CAS  PubMed  Google Scholar 

  74. Munks MW, Pinto AK, Doom CM, Hill AB (2007) Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. J Immunol 178:7235–7241

    Article  CAS  PubMed  Google Scholar 

  75. Reddehase MJ, Simon CO, Podlech J, Holtappels R (2004) Stalemating a clever opportunist: lessons from murine cytomegalovirus. Hum Immunol 65:446–455

    Article  CAS  PubMed  Google Scholar 

  76. Lu X, Pinto AK, Kelly AM, Cho KS, Hill AB (2006) Murine cytomegalovirus interference with antigen presentation contributes to the inability of CD8 T cells to control virus in the salivary gland. J Virol 80:4200–4202

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Simon CO, Holtappels R, Tervo HM, Bohm V, Daubner T, Oehrlein-Karpi SA, Kuhnapfel B, Renzaho A, Strand D, Podlech J et al (2006) CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J Virol 80:10436–10456

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Cicin-Sain L, Podlech J, Messerle M, Reddehase MJ, Koszinowski UH (2005) Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J Virol 79:9492–9502

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Hedrick SM (2004) The acquired immune system: a vantage from beneath. Immunity 21:607–615

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the NIH AI047206 and AI0570099.

Author information

Authors and Affiliations

  1. Department of Molecular Microbiology and Immunology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA

    Carmen M. Doom & Ann B. Hill

Authors
  1. Carmen M. Doom
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ann B. Hill
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ann B. Hill.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Doom, C.M., Hill, A.B. MHC class I immune evasion in MCMV infection. Med Microbiol Immunol 197, 191–204 (2008). https://doi.org/10.1007/s00430-008-0089-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00430-008-0089-y

Keywords

Search

Navigation